GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Avery Dennison Reports 7% Decline in Q4 Net Sales to $2.02 Billion Amid Reduced Market Demand

by GOAI
Share To

Avery Dennison released its financial results for the fourth quarter and full year of 2025. The company reported a decline in net sales for both periods, citing challenging market conditions as a contributing factor. For the fourth quarter, net sales totaled $2.02 billion, reflecting a decrease of approximately 7% compared to the same period in 2024. Full-year net sales reached $8.12 billion, marking an overall decline of about 6% from the previous year.

The report highlighted that organic sales decreased by 5% for the fourth quarter and 4% for the full year. Avery Dennison attributed these declines primarily to reduced demand across several key markets, including retail branding and information solutions (RBIS) and industrial labeling sectors. Despite lower sales figures, adjusted earnings per share (EPS) for the fourth quarter stood at $2.16, while full-year adjusted EPS was reported at $9.01. The company stated it continues to focus on operational efficiencies and cost management strategies amid ongoing economic challenges impacting its business segments globally.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Lilly Acquires Orna Therapeutics in $2.4B to Scale In Vivo CAR-T Cell Therapies
2026-02-10
CCHH Receives Nasdaq Notice for Falling Below $1.00 Minimum Bid Price
2026-02-10
South African Patent Office Grants Manganese X Energy Corp. Patent for High-Purity Manganese Processing Technology
2026-02-10
Study Explores Impact of Symptoms on Health-Related Quality of Life in Older Swedish Men
2026-02-10
Study Finds Gaps in Support Systems for Parents Using At-Home Medical Devices for Children with Complex Needs
2026-02-10
Radiopharmaceutical Industry Faces Talent Shortage Amid Rapid Expansion
2026-02-10
FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top